Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

Clinical trial NCT05453695 · RECRUITING

Trial details

NCT number: NCT05453695
Sponsor: McMaster University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sepsis Critical Illness

Start date: 2023-01-17
Primary completion: 2026-05-28
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.